Selected Publications
For complete publications list, see Dr. Zaworotko's
Curriculum Vitae
C = communication, F = full paper, R = Review, # = SciFinder® citations 10/2007, in chronological order, 5 most relevant followed by recent, out of over 250 refereed papers since 1992:
-
(C, # = 485) Wilkes, J.S.; Zaworotko, M.J. "Air and Water Stable 1-methyl-3-ethylimidazolium Based Ionic Liquids".
J. Chem. Soc., Chem. Comm., 965, 1992.
The first report of air and water stable ionic liquids.
-
(C, # = 373) Subramanian, S.; Zaworotko, M.J. "Porous Solids by Design:
[Zn(4,4'-dipyridyl)2(SiF6)]∞•x DMF, a Single Framework Octahedral Coordination Polymer with Large Square Channels"
Angew. Chem., Int. Ed. Engl., 34, 2127-29, 1995.
The first report of an open framework octahedral coordination polymer.
-
(C, # = 423) Hennigar, T.L.; Losier, P.; MacQuarrie, D.C.; Zaworotko, M.J.; Rogers, R.D. "Supramolecular Isomerism in
Coordination Polymers: Manifestations of Ligand Flexibility in [Co(NO3)2(1,2-bis(4-pyridyl)ethane)1.5]n".
Angew. Chem., Int. Ed. Engl., 36, 972-973, 1997.
The first report of supramolecular isomerism in coordination polymers.
-
(R, # = 452) Zaworotko, M.J. “Superstructural Diversity in Two Dimensions: Crystal Engineering of Laminated Solids”, Chem. Commun., 1-9, 2001.
-
(R, # = 1768) Moulton, B.; Zaworotko, M.J. "From Molecules to Crystal Engineering: Supramolecular Isomerism and Polymorphism in Network Solids", Chemical Reviews, 101, 1629-1658, 2001.
-
(C, # = 94) Abourahma, H.; Moulton, B.; Kravtsov, V.; Zaworotko, M.J. "Supramolecular Isomerism in Coordination Compounds:
Nanoscale Molecular Hexagons and Chains" J. Amer. Chem. Soc., 124, 9990-9991, 2002.
-
(F, # = 70) Fleischman, S.G.; Kuduva, S.S.; McMahon, J.A.; Moulton, B.; Bailey Walsh, R.D.; Rodriguez-Hornedo, N.; Zaworotko, M.J. “Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine.” Crystal Growth & Design, 3, 909-919, 2004.
-
(R, # = 89) Almarsson, Ö.; Zaworotko, M.J. "Crystal Engineering of the Composition of Pharmaceutical Phases. Do Pharmaceutical
Co-crystals Represent a New Path to Improved Medicines?" Chem. Commun., 1889-1896, 2004.
Supramolecular synthesis in the context of pharmaceutical molecules.
-
(C, # = 31) Vishweshwar, P.; McMahon, J.A.; Oliveira, M.; Peterson, M.L.; Zaworotko, M.J. “The predictably elusive form II of aspirin.” J. Am. Chem. Soc., 127, 16802-16803, 2005.
-
(R, # = 11) Zaworotko, M.J. “Molecules to Crystals, Crystals to Molecules ... and Back Again?” Crystal Growth & Design, 7, 4-9, 2007.
-
(F) McManus, G.J.; Perry, J.J.; Perry, M.; Wagner, B.D.; Zaworotko, M.J. “Exciplex fluorescence as a diagnostic probe of structure in coordination polymers of Zn2+ and 4,4’-bipyridine containing intercalated pyrene and enclathrated aromatic solvent guests.”, J. Am. Chem. Soc., 129, 9094-9101, 2007.
-
(C) Perry, J.J.; Kravtsov, V. Ch; McManus, G.J.; Zaworotko, M.J. “Bottom up Synthesis That Does Not Start at the Bottom: Quadruple Covalent Cross-Linking of Nanoscale Faceted Polyhedra.”, J. Am. Chem. Soc., 129, 1076-77, 2007.